Imaging histone deacetylases with a radiotracer using positron emission tomography
AssigneeThe General Hospital Corporation
InventorsJacob M. Hooker, Changning Wang, Frederick Albert Schroeder
Life of this patent
Estimating the term…
Abstract
Disclosed herein are histone deacetylase imaging agents for positron emission tomography and related imaging methods using the histone deacetylase imaging agents. The histone deacetylase imaging agents may be a compound of formula (I): wherein R1 is a moiety including a positron emitter; R2 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and n is an integer selected from 0 or 1. In one version of the compound of formula (I), R1 is a moiety including an adamantyl group.
Claims25
A method for the treatment of a condition involving a histone deacetylase, the method comprising:
- administering to a subject having the condition a therapeutically effective amount of a compound of formula (I):
- wherein R1 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocyclic,
- wherein R2 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocyclic, and
- wherein n is an integer selected from 0 or 1.
A method for the treatment of a condition involving a histone deacetylase, the method comprising:
- administering to a subject having the condition a therapeutically effective amount of a compound of formula (III):
- wherein R3 is represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocyclic, and
- wherein R4 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocyclic.
A compound of formula (I):
- wherein R1 is a moiety including a bridged carbocycle,
- wherein R2 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocyclic, and
- wherein n is an integer selected from 0 or 1.
A compound of formula (III):
- wherein R3 is a moiety including a bridged carbocycle, and
- wherein R4 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocyclic.
Dependencies are inferred from the claim text.